Surveillance of natural acquired antibodies to Haemophilus in fluenzae type b among children in Cairo-Egyptian

Human Antibodies

Volumn 14, Issue 1-2, 2005, Pages 23-26

  Redwan, El Rashdy M ^a   Elsawy, Abdelrahman ^b  

^a Universities and Research centers District   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; EGYPT; ENZYME IMMUNOASSAY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH SURVEY; HUMAN; INFANT; INNATE IMMUNITY; MALE; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; SAMPLE SIZE;

EID: 30944442067     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2005-141-204     Document Type: Article

References (19)

1. F. Ballereau, M. Speich and V. Apaire-Marchais, Natural Haemophilus influenzae type b capsular polysaccharide antibodies in 412 infants and children from West Africa (Burkina-Faso) and France: A cross-sectional serosurvey, Eur J Epidemio 15 (1999), 577-582.
2. J.M. Puliyel, K.S. Agarwal and F.A. Abass, Natural immunity to haemophilus influenzae b in infancy in Indian children, Vaccine 19 (2001), 4592-4594.
3. D.R. Feikin, C.B. Nelson, J.P. Watt, E. Mohsni, J.D. Wenger and O.S. Levine, Rapid assessment tool for Haemophilus influenzae type b disease in developing countries, Emerg Infect Dis 10 (2004), 1270-1276.
4. S. Rerks-Ngarm, S.C. Treleaven, S. Chunsuttiwat, C. Muagnchana, D. Jolley, A. Brooks et al., Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand, Vaccine 22 (2004), 975-983.
5. M.P. Helena, H. Nohynek and H. Elja, Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand, Vaccine 23 (2004), 2687-2688.
6. M.R. Lmcangco, E.G. Salole and C.L. Armour, Epidemiology of Haemophilus influenzae type b meningitis in Manila, Philippines, 1994 to 1996, Pediatr Infect Dis J 19 (2000), 7-11.
7. P.W. Anderson and R.J. Eby, European patent 0245045A2, Parxis Biologics, Inc., 1987.
8. P.W. Anderson and R.J. Eby, US Patent 4902506, University of Rochester.
9. A. Barra, D. Schulz, P. Aucouturier and J.L. Preud'homme, Measurment of anti-Haemophilus influenzae type b capsular polysaccharide antibodies by ELISA, J Immunol Methods 115 (1988), 111-117.
10. H. Kaythy, J. Eskola, H. Peltola, L. Saarinen and P.H. Makela, High antibody responses to booster doses of either Haemophilus influenzae type b capsular polysaccharide or conjugates vaccine after primary immunization with conjugated vaccines, J Infect Dis 165(Suppl. 1)(1992), S165-S166.
11. Y. Tastan, M. Alikasifoglu, O. Liter, E. Erginoz, A. Arvas, D. Yuksel and S. Badur, Natural immunity to Haemophilus influenzae type b among healthy children in Istanbul, Turkey. Indian Pediatr. 37 (2000), 414-417.
12. D. Acharya, S. Bhave, V. Joshi, A. Bavdekar and A. Pandit, Haemophilus influenzae type b in India: need and timing, immunogenecity and tolerance, Indian Pediatr 34 (1997), 9-15.
13. G.T. Peraza, I.H. Vadell, M.E. Romani, A. Baly Gil, I.T. Martinez and A.C. Garcia, Naturally acquired immunity to Haemophilus influenzae type b in healthy Cuban children, Mem Inst. Oswaldo Cruz 99 (2000), 1-5.
14. A.K. Takala, J. Eskola, M. Leimonen, H. Kaythy, A. Nissinen, E. Pekkanen and P.H. Makela, Reduction of oropharyngeal carriage of Haemophilus influenzae type b in children immunized with an Hib conjugate vaccine, J Infect Dis 164 (1991), 982-986.
15. M. Bradshaw, R. Schneerson, J. Parke and J.B. Robbins, Bacterial antigens cross reactive with capsular polysaccharide of Haemophilus influenzae type b, Lancet 1 (1971), 1095-1096.
16. J.B. Robbins, R. Schneerson, M. Argaman and Z.T. Handzel, Haemophilus influenzae type b: disease and immunity in human, Ann Internal Med 78 (1973), 259-269.
17. R. Schneerson and J.B. Robbins, Induction of serum Haemophilus influenzae type b capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:k100:h5, New England J Med 292 (1995), 1093-1096.
18. N.W. Preston, Why the rise in Haemophilus influenzae type b infections, Lancet 362 (2003), 320-331.
19. WHO 1998, Global Programme for Vaccines and Immunization. The WHO position paper on Haemophilus influenzae type b conjugate vaccines, WER 73 (1998), 64-68.